FindTrial
Sign In

Long term sugar control in liver disease patients with outcome in postoperative liver transplant

Preoperative HbA1c level And Postoperative Morbidity And Mortality In Liver Transplant Patients: A Retrospective Study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2018/04/012966
Enrollment
400
Registered
2018-04-03
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Liver transplant patients operated for chronic liver disease

Interventions

None listed

Sponsors

Institute of Liver and Biliary Science New Delhi
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients operated for Liver transplant From 2010 to September 2016 were included

Exclusion criteria

Exclusion criteria: Patients with age less than 18 years, Incomplete medical records, Patients operated for acute on chronic liver failure, and for acute liver failure were excluded

Design outcomes

Primary

MeasureTime frame
preoperative HbA1c level and post-operative mortality and morbidity in patients of liver transplantTimepoint: During stay in intensive care unit—

Secondary

MeasureTime frame
Data was also collected for insulin requirement, need for renal replacement therapy, infections, episodes of cellular rejection requiring steroid pulse therapy, duration of mechanical ventilation, need for re-exploration surgery and duration of ICU and hospital stay.Timepoint: During stay in intensive care unit—

Countries

India

Contacts

Public ContactDr Manish Tandon

Institute of Liver and Biliary Science, New Delhi

tandym25@gmail.com9540946860

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 22, 2026